In I/R-induced AKI, targeted SIRT3 activation produces multifaceted nephroprotective effects, including deacetylation of mitochondrial SOD2, enhancing antioxidative capacity, and suppressing pathological superoxide accumulation299. The gene discussed is SOD2; the disease is acute kidney injury.